Argenx Bvba competitive analysis

Latest publications and patents of Argenx Bvba New

Explore the latest publications and patents granted to Argenx Bvba, showcasing their recent innovations and technological advancements.

Last updated on: Sep 24, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Argenx Bvba

Oct 23, 2024Bispecific Antigen Binding ConstructGranted And Under Opposition
Jun 26, 2024Use Of Anti Cd70 Antibody Argx-110 To Treat Acute Myeloid LeukaemiaGranted And Under Opposition
Aug 7, 2019Fcrn Antagonists And Methods Of UseGranted And Under Opposition

Explore Argenx Bvba's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
Oct 23, 2024Bispecific Antigen Binding Construct2
Jun 26, 2024Use Of Anti Cd70 Antibody Argx-110 To Treat Acute Myeloid Leukaemia1
Aug 7, 2019Fcrn Antagonists And Methods Of Use1

Latest PTAB cases involving Argenx Bvba

Discover the latest PTAB cases involving Argenx Bvba, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Argenx Bvba with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ARGENX BVBA - 4 - - Non-Active
PFIZER50864312Aggressive
SANOFI5923 - - Highly Aggressive
SIMMONS & SIMMONS7 - - - Highly Aggressive